Shane Reeves

Nov 6, 2024 | medcitynews.com | Shane Reeves |Monica Vajani |Stephanie Baum

As Chief Executive Officer of TwelveStone Health Partners, Shane Reeves leads all aspects of the business, including product, marketing, sales, finance, and delivery strategy. Shane’s career began with the organization in 1994 when he joined the family business and worked his way up through every function in the company.

Sep 9, 2024 | medcitynews.com | Shane Reeves |Monica Vajani

As Chief Executive Officer of TwelveStone Health Partners, Shane Reeves leads all aspects of the business, including product, marketing, sales, finance, and delivery strategy. Shane’s career began with the organization in 1994 when he joined the family business and worked his way up through every function in the company.

Jun 13, 2024 | medcitynews.com | Shane Reeves

Drug design and development is expensive, often insufficient, and laced with the tendency for failure. Traditionally, it’s a hit-and-miss process that can stretch over a decade and consume around $2.3 billion — figures that have only climbed higher recently; with a 15% increase in costs among top global biopharmaceutical firms last year alone.

Feb 9, 2024 | healthcarebusinesstoday.com | Shane Reeves

Despite the overarching impact that artificial intelligence (AI) is having in the field of medicine, physicians, pharmacists, and other healthcare professionals remain skeptical of its use. For all the publicity, AI is still relatively new. Although the potential in medicine is undoubtedly expansive, stringent regulations are still not in place, meaning that AI based medical technology and solutions have hurdles that are unique to this industry.